Tandem Capital Management Corp Perkinelmer Inc Transaction History

Tandem Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$115.88 - $122.81 $15,759 - $16,702	-136 Reduced 3.72%	3,519 $425,000
Q2 2023 Aug 15, 2023	SELL	$0.0 - $137.11 $0 - $34,963	-255 Reduced 6.52%	3,655 $0
Q4 2022 Jan 18, 2023	SELL	$119.0 - $147.98 $673,659 - $837,714	-5,661 Reduced 59.15%	3,910 $0
Q3 2022 Oct 24, 2022	BUY	$118.07 - $160.96 $2,361 - $3,219	20 Added 0.21%	9,571 $1.25 Million
Q2 2022 Jul 19, 2022	BUY	$134.91 - $172.49 $23,474 - $30,013	174 Added 1.86%	9,551 $1.36 Million
Q1 2022 Apr 26, 2022	BUY	$162.31 - $192.2 $89,919 - $106,478	554 Added 6.28%	9,377 $1.43 Million
Q4 2021 Feb 04, 2022	BUY	$166.66 - $201.06 $891,964 - $1.08 Million	5,352 Added 154.19%	8,823 $1.77 Million
Q3 2021 Oct 28, 2021	BUY	$151.98 - $190.5 $310,495 - $389,191	2,043 Added 143.07%	3,471 $601,000
Q2 2021 Aug 06, 2021	BUY	$127.81 - $155.84 $182,512 - $222,539	1,428 New	1,428 $220,000

574

108M

57.1K

23.1K

Ticker PKI
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 126,224,000
Market Cap $15.3B
Description
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detectio...

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

Stay updated on Tandem Capital Management Corp with notifications on news.